“The upgrade reflects expected benefits from this issuance, which should lower [outstanding] debt, debt service and interest rate expense, and eliminate all contingent debt,” said S&P analyst Margaret McNamara.
The outlook is stable, reflecting Norman’s solid market position, record of improved earnings and solid balance sheet for the new rating.
More articles on healthcare finance:
Fitch assigns ‘BBB-‘ rating to Oaklawn Hospital’s bonds
Medicare pays some hospitals double what it pays others for surgical complications
Amidst the angst, value-based care is working
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
